FlexMed No Needles. No Blood. No Pain.
Roadmap
- Discovery of Flexmed's unique method for membrane permeabilization to access interstitial fluid (ISF) transdermally enables measurement of substances in the body without pain, blood or skin puncture. These are some of the areas our core technology can be applied:
- In addition to glucose, biomarkers such as bilirubin, urea, and others can be monitored for indication of liver and kidney function. Body levels of lactic acid, potassium, bicarbonate, and pH also provide critical information about health condition of the subject that can improve or even save lives.
- Compounds such as alcohol, anabolic steroids, Hydrocodone, and others could be instantly measured by the same transdermal ISF extraction and fluidic system. Flexmed has received a grant from the NIH to develop alcohol sensing, and will expand the platform to include other drugs in the future.
- Imagine the value of instantaneous screening for pathogen markers in the event of a global pandemic such as the recent bird flu. Screening of visitors through airports or schools could protect the safety of our citizens and our children. Military personnel could be protected by routine monitoring for chemical or biological exposure.
- Proper dosage of pharmaceuticals presents challenge for doctors because patients are different and have different drug uptake and metabolic rates. Monitoring these compounds in the body would be a useful tool, assuring the body level is correct.
- Exciting possibilities become real opportunities when new discoveries are applied to old problems. These are some of
the areas we will apply our membrane permeabilization technology in the future:
Continuous Real-Time Analyte Monitoring and Transmission of Results
Transdermal Drug Delivery